Aquestive Therapeutics AQST Earnings Call Transcripts

NASDAQ AQST
$3.52 -0.02 (-0.56%)
At close: Nov 10, 2026 · 4:00 PM EST
14 earnings calls on file for Aquestive Therapeutics, from Q4 2019 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Aquestive Therapeutics Q3 2026 Earnings Call

Nov 4, 2026 8,223 words · 36 min read
  • Faith Pomeroy WardInvestor Relations
  • Daniel BarberPresident and Chief Executive Officer
  • A. Ernest Toth Jr.Chief Financial Officer
  • Dr. Matt GreenhawtChief Medical Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Aquestive Therapeutics Earnings Call Transcripts

Calls14
LatestNov 4, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2022

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 14 Aquestive Therapeutics transcripts Register to get access to Aquestive Therapeutics’s earnings call transcripts.